Skip to content

Examining the effects of Ionix Supreme on stress, mood, energy and anxiety.

Examining the effects of Ionix Supreme on stress, mood, energy and anxiety in healthy younger adults.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617000698370
Enrollment
72
Registered
2017-05-16
Start date
2017-09-27
Completion date
2018-07-17
Last updated
2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This research project is aiming to determine the effects of Ionix Supreme on stress, mood, energy and anxiety. Despite the widespread use of vitamins to compensate for the busy lifestyle and irregular eating patterns that often accompany busy modern lifestyles, there are few controlled trials directly investigating the relationship between dietary supplements on stress, mood, energy and anxiety. We will be measuring the effects Ionix Supreme compared to a placebo using assessments of mental performance, mood and stress measures, along with the collection of blood samples. A smaller group of participants will be invited to participate in a brain imaging component using Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS). These scans will allow us to assess the effects the supplement may have on the brain.

Interventions

Ionix Supreme liquid Oral liquid, 60mL daily for 4 weeks Medicinal ingredients include (per 30ml) Chinese Wolfberry 100 mg Betaine hydrochloride 20mg Velvet-bean 30 mg Methylsulfonylmethane, synthetic 20mg Maca 10 mg Shilajeet 20mg DL-alpha-Lipoic acid 25mg Siberian-ginseng 25 mg Ashwagandha 30 mg Schisandra 15 mg Tribulus 20 mg Bacopa 25mg Chebulic myrobalan 25mg Roseroot 30mg Indian-gooseberry 25mg Niacinamide 13mg Vitamin B6 6mg Zinc 5mg Vitamin B2 4mg Ginger 5mg Vitamin b12 120mcg Yellow rho

Ionix Supreme liquid Oral liquid, 60mL daily for 4 weeks Medicinal ingredients include (per 30ml) Chinese Wolfberry 100 mg Betaine hydrochloride 20mg Velvet-bean 30 mg Methylsulfonylmethane, synthetic 20mg Maca 10 mg Shilajeet 20mg DL-alpha-Lipoic acid 25mg Siberian-ginseng 25 mg Ashwagandha 30 mg Schisandra 15 mg Tribulus 20 mg Bacopa 25mg Chebulic myrobalan 25mg Roseroot 30mg Indian-gooseberry 25mg Niacinamide 13mg Vitamin B6 6mg Zinc 5mg Vitamin B2 4mg Ginger 5mg Vitamin b12 120mcg Yellow rhododendron 25mg Non-medicinal ingredients: Kiwi fruit extract, watermelon juice, Hibiscus flower, Silica, alfalfa extract, Blueberry extract, Stevia leaf, DL-malic acid, apple flavour, apple juice, sodium chloride, Water, molasses, potassium sorbate, potassium sorbate, sodium citrate Compliance will be measured by measurement of returned liquid and by a treatment taking log

Sponsors

Swinburne University of Technology, Centre for Human Psychopharmacology
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Fluent in written and spoken English In good general health Normal or corrected to normal vision

Exclusion criteria

Smoker Diabetes, cardiovascular disease, epilepsy, Parkinson's Disease, Dementia, stroke or other neurological conditions, depression/anxiety or other psychiatric conditions in the last 2 years, endocrine, gastrointestinal or bleeding disorders. Alcohol abuse (past/present) If female, not currently pregnant or lactating Use of antidepressant or anti-anxiety medications Use of high dose anti-coagulant medications Use of vitamin E, multivitamins, B vitamin complex, ginkgo biloba, fish oil, St John’s Wort or other cognitive enhancing dietary or herbal supplement in the 4 weeks preceding the baseline study visit

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026